SCHEMBL4149879

SCHEMBL4149879

O=C(Nc1[c]cccc1)c1ccccc1F

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
TDP1 Q9NUW8 1/20 0.59
LMNA P02545 2/20 0.54
GAA P10253 3/20 0.51
NPC1 O15118 8/20 0.51
SMN1; SMN2 Q16637 7/20 0.51
RAB9A P51151 7/20 0.51
HTT P42858 1/20 0.51
MAPT P10636 3/20 0.49
ALDH1A1 P00352 3/20 0.49
HPGD P15428 1/20 0.49
TP53 P04637 2/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
KDM4E B2RXH2 1/20 0.46
GLA P06280 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4289330 0.80 FADS1 (0.50) GAANPC1SMN1; SMN2RAB9AMAPT
SCHEMBL482522 0.80 HPGD (0.57) NPC1SMN1; SMN2RAB9AHTTMAPT
SCHEMBL6805383 0.78 MMP3 (0.56) MEN1KMT2AGAANPC1SMN1; SMN2
SCHEMBL7641652 0.77 MEN1 (0.59) MEN1KMT2ATDP1NPC1SMN1; SMN2
SCHEMBL5123859 0.76 HTT (0.55) MEN1KMT2ATDP1LMNAGAA
SCHEMBL6110708 0.76 JAK2 (0.52) MEN1KMT2ANPC1SMN1; SMN2RAB9A
SCHEMBL10532020 0.76 DDX3X (0.44) KMT2ALMNAGAAMAPTALDH1A1
SCHEMBL429187 0.75 PTPN1 (0.48) MEN1KMT2ATDP1NPC1SMN1; SMN2
SCHEMBL9725165 0.74 SMN1; SMN2 (0.44) MEN1KMT2ALMNANPC1SMN1; SMN2
SCHEMBL27888664 0.73 MEN1 (0.57) MEN1KMT2ALMNANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009078587-A2 COMPOSITION FOR PREVENTION AND TREATMENT OF CANCER CONTAINING TRIAZOLYL-THIO-ETHANONE DERIVATIVES INHIBITING ACTIVITY OF PROTEIN PHOSPHATASES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS AN ACTIVE INGREDIENT KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2009-06-25 WO disclosed